Milner Seminars​

Our seminar series is designed to facilitate interdisciplinary connections and provide a range of insights​ on disease and therapeutic approaches. Seminars include speakers from both academia and industry/biotech, each addressing a common theme, and are followed by networking over refreshments. To encourage informal discussion, these events are held in person at the Jeffrey Cheah Biomedical Centre. For our national and international delegates, many of the talks will later become available to view on our YouTube channel

To sign up for emails with information about future events in the Seminar Series, please complete this form and if you have any questions, please email events@milner.cam.ac.uk

Next Up: focus on immuno-oncology

Thursday, 28th November
4:00-5:00pm, followed by networking
Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus

 

Simon Dovedi, AstraZeneca
“Taking T cell engagement to the next level: Generating CD8 Selective T Cell Engager Molecules”

 

and

 

Maike de la Roche, CRUK Cambridge Institute, University of Cambridge
“Novel immunotherapeutics against LGR5+ cancers”

Headshot of Guy Brown
Headshot of Maike de la Roche

Future Seminar Dates

Future seminars are scheduled for the dates below.
This page will be updated with speaker and registration information ahead of each event.
All seminars take place at 4pm in the Lecture Theatre at the Jeffrey Cheah Biomedical Centre.

28th November, 2024
Focus on immuno-oncology

29th January, 2025
26th March, 2025
21st May, 2025

Previous Seminar Speakers

A list of our previous seminar speakers can be found by expanding the box below. Many past seminars can be viewed on our YouTube channel

Previous Seminar Series Speakers

26th September, 2024
Mark Toshner, Victor Philip Dahdaleh Heart and Lung Research Institute, University of Cambridge
Salvatore Simmini, STEMCELL Technologies

5th June, 2024
Heike Laman, Department of Pathology, University of Cambridge
Benedict Cross, Phoremost

25th April 2024
Guy Brown, Department of Biochemistry, University of Cambridge
Yujing Gao, Astex

29th February 2024
Goncalo Bernardes, Yusuf Hamied Department of Chemistry, University of Cambridge
Louise Hosie, Epitopea

12th December 2023
Malcom Roberts, Eisai
Lee Dawson, Cerevance

18th October 2023
Matteo Martufi, GSK
Emma Rawlins, Gurdon Institute, University of Cambridge

25th May 2023
Philippe Sanseau, GSK

27 April 2023
William McEwan, UK Dementia Research Institute and Department of Clinical Neurosciences, University of Cambridge

30th March 2023
Menna Clatworthy, CITIID

23rd February 2023
Bristi Basu, Department of Oncology, University of Cambridge

26th January 2023
George Malliaras, Department of Engineering, University of Cambridge

24th November 2022
Camilla Fairbairn, bit.bio

19th October 2022
Ian Roberts, Healx

26th May 2022
Alex Taylor,CITIID

28th April 2022
Sabine Bahn, Department of Chemical Engineering and Biotechnology, University of Cambridge

31st March 2022
Chiara Bacchelli, Lifebit
Pablo Prieto Barja,Lifebit
Thorben Seeger, Lifebit

24th February 2022
Daniel Munoz-Espin, Department of Oncology, University of Cambridge

27th January 2022
Ziad Mallat, Department of Medicine, University of Cambridge

25th November 2021
Omer Bayraktar, The Wellcome Sanger Institute

21st October 2021
Joanna Betts,GSK

23rd September 2021
Adrian Liston, The Babraham Institute

17th May 2021
Benedict Cross, Phoremost

29th April 2021
Fiona Gribble, Wellcome MRC Institute of Metabolic Science

25th March 2021
Mike Murphy, MRC Mitochondrial Biology Unit

25th February 2021
Elena di Daniel, Astex

17th December 2020
Manav Pathania, Milner Therapeutics Institute, University of Cambridge

26th November 2020
Trevor Lawley, Microbiotica

22nd October 2020
Mike Stratton, Wellcome Sanger Institute

14th May 2020
Jason Carroll, CRUK Cambridge Institute

30th April 2020
Robin Franklin, Wellcome-MRC Cambridge Stem Cell Institute

26th March 2020
Mathew Garnett, Wellcome Sanger Institute

27th February 2020
Ludovic Vallier, Wellcome-MRC Cambridge Stem Cell Institute
Pal Mander, GSK

30th January 2020
James Nathan, CITIID
Namshik Han, Milner Therapeutics Institute, University of Cambridge